**FDA-approved Indications**

- Oral zolmitriptan

- 
              
- Acute treatment of migraine with aura in adults 
              
              
- Acute treatment of migraine without aura in adults

- Nasal spray zolmitriptan

- 
              
- Acute migraine treatment in pediatric patients ages 12 and older and adults

**Off-label Clinical Uses**

- Acute treatment of cluster headaches (nasal spray)—Level A recommendation from the American Academy of Neurology.

- Acute treatment of menstrual migraine

Zolmitriptan is efficacious in the acute treatment of migraine headache pain and associated symptoms of nausea, vomiting, phonophobia, and photophobia.****Zolmitriptan was significantly more effective at helping patients achieve pain-free status at 2 hours, 3 hours, and 4 hours post-treatment compared to placebo.